Tentative Program

This track will explore the latest advancements in pharmacotherapy for obesity, focusing on novel drug mechanisms and their clinical implications. Researchers are encouraged to present findings on efficacy, safety, and patient adherence to obesity medications.

This session will delve into the intricate metabolic pathways that contribute to diabetes onset and progression. Presentations will highlight recent discoveries in metabolic regulation and their potential therapeutic targets.

This track will examine the effectiveness of behavioral interventions in promoting weight loss and preventing diabetes. Studies on lifestyle modifications, counseling techniques, and community-based programs are particularly welcome.

This session will focus on the emerging role of gut microbiota in the pathophysiology of obesity and diabetes. Researchers are invited to present data on microbiome composition, function, and its implications for therapeutic strategies.

This track will highlight cutting-edge technologies such as wearable devices, mobile health applications, and telemedicine in managing obesity and diabetes. Contributions should address the impact of these innovations on patient outcomes and healthcare delivery.

This session will explore dietary interventions and nutritional strategies aimed at controlling obesity and diabetes. Presentations should focus on evidence-based approaches, including macronutrient composition and meal timing.